Skip to main content

Table 5 Summary of base model and special sensitivity analysis results

From: An economic model of long-term use of celecoxib in patients with osteoarthritis

Model features No age risks Sensitivity analyses with age risks
Lifetime models   
Base model $31,097 $19,309
Alternative treatments after UGI events models $38,807–$46,192 $26,201–$31,777
CV thromboembolic risks 1[15] $17,120 $7,923
Other analytic horizons   
1 year $124,100 $124,100
5 years $108,549 $104,104
8 years $93,420 $85,534
11 years $67,812 $58,459
12 years $61,191 $51,521
  1. UGI, upper gastrointestinal; CV, cardiovascular.